INS and type 1 diabetes mellitus: Type 1 diabetic (T1DM) patients treated with unmodified regular human insulin (RHI) rarely achieve their glycaemic target and often suffer from postprandial hyperglycaemic excursions, together with an increased risk of hypoglycaemia in the post-absorptive period [1].